Health
‘Baricitinib’: This arthritis drug may improve Covid survival in elderlies – ummid.com
This is one of the first Covid-19 treatments to go from computer to clinic and laboratory, study authors said
London: Scientists have claimed that a type of arthritis drug called ‘baricitinib’ may reduce the risk of dying among elderly patients infected with Covid-19.
This medication is usually used to treat rheumatoid arthritis, and was initially identified by the Imperial College London using artificial intelligence as a drug that could have anti-viral and anti-inflammatory effects.
In the early-stage study, 83 patients, with a median age of 81 and all suffering from moderate to severe COVID-19 infection,…
-
Business22 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News21 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
General16 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News18 hours agoTips to improve engagement – Proctor